Clinical Trials Directory

Trials / Unknown

UnknownNCT02871232

Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS): RADARS® System Surveillance Protocol

Status
Unknown
Phase
Study type
Observational
Enrollment
26,500 (estimated)
Sponsor
ER/LA Opioid REMS Program Companies (RPC) · Industry
Sex
All
Age
Healthy volunteers

Summary

To conduct surveillance for abuse, misuse, overdose, addiction, and death and to evaluate if the REMS meets its surveillance goals, and if it does not, to modify it appropriately based on the metrics. Briefly, therefore, the overall surveillance objective is to evaluate for trends before and after the shared REMS is implemented to collectively assess for changes in abuse, misuse, overdose, addiction, and death for different risk groups and settings.

Conditions

Interventions

TypeNameDescription
OTHERResearched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System of post-marketing surveillance of prescription medication abuse, misuse, and diversion

Timeline

Primary completion
2016-12-01
First posted
2016-08-18
Last updated
2016-08-25

Source: ClinicalTrials.gov record NCT02871232. Inclusion in this directory is not an endorsement.